Search Results - "Baihua Hu"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1).

    Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1).

    Chan, Bryan K.1 chan.bryan@gene.com, Seward, Eileen2, Lainchbury, Michael2, Brewer, Thomas F.1, Le An1, Blench, Toby2, Cartwright, Matthew W.2, Chan, Grace Ka Yan1, Choo, Edna F.1, Drummond, Jason1, Elliott, Richard L.2, Gancia, Emanuela2, Gazzard, Lewis1, Baihua Hu3, Jones, Graham E.2, Xifeng Luo3, Madin, Andrew2, Malhotra, Sushant1, Moffat, John G.1, Pang, Jodie1

    Linked Full Text
    Save to List
  2. 2
    Discovery of a Potent (4R,5S)-4-Fluoro-5-methylproline Sulfonamide Transient Receptor Potential Ankyrin 1 Antagonist and Its Methylene Phosphate Prodrug Guided by Molecular Modeling.

    Discovery of a Potent (4R,5S)-4-Fluoro-5-methylproline Sulfonamide Transient Receptor Potential Ankyrin 1 Antagonist and Its Methylene Phosphate Prodrug Guided by Molecular Modeling.

    Huifen Chen1 chen.huifen@gene.com, Volgraf, Matthew1 volgraf.matthew@gene.com, Do, Steven1, Kolesnikov, Aleksandr1, Shore, Daniel G.1, Verma, Vishal A.1, Villemure, Elisia1, Lan Wang1, Yong Chen2, Baihua Hu2, Ai-Jun Lu2, Guosheng Wu2, Xiaofeng Xu2, Po-Wai Yuen2, Yamin Zhang2, Erickson, Shawn D.3, Dahl, Martin3, Brotherton-Pleiss, Christine3, Tay, Suzanne4, Ly, Justin Q.4

    Linked Full Text
    Save to List
  3. 3
    Structure-Based Approach To Identify 5-[4-Hydroxyphenyl]pyrrole-2-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators.

    Structure-Based Approach To Identify 5-[4-Hydroxyphenyl]pyrrole-2-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators.

    Unwalla, Ray1 ray.unwalla@pfizer.com, Mousseau, James J.1, Fadeyi, Olugbeminiyi O.1, Chulho Choi1, Parris, Kevin1, Baihua Hu1, Kenney, Thomas1, Chippari, Susan1, McNally, Christopher1, Vishwanathan, Karthick1, Kilbourne, Edward1, Thompson, Catherine1, Nagpal, Sunil1, Wrobel, Jay1, Yudt, Matthew1, Morris, Carl A.1, Powell, Dennis1, Gilbert, Adam M.1, Chekler, Eugene L. Piatnitski1 piatnits@gmail.com

    Linked Full Text
    Save to List
  4. 4
    Tetrahydroindazoles as Interleukin-2InducibleT-Cell Kinase Inhibitors. Part II. Second-Generation Analogueswith Enhanced Potency, Selectivity, and Pharmacodynamic Modulationin Vivo.

    Tetrahydroindazoles as Interleukin-2InducibleT-Cell Kinase Inhibitors. Part II. Second-Generation Analogueswith Enhanced Potency, Selectivity, and Pharmacodynamic Modulationin Vivo.

    JasonD. Burch1, Kathy Barrett1, Yuan Chen1, Jason DeVoss1, Charles Eigenbrot1, Richard Goldsmith1, M. Hicham A. Ismaili1, Kevin Lau1, Zhonghua Lin1, Daniel F. Ortwine1, Ali A. Zarrin1, Paul A. McEwan1, John J. Barker1, Claire Ellebrandt1, Daniel Kordt1, Daniel B. Stein1, Xiaolu Wang1, Yong Chen1, Baihua Hu1, Xiaofeng Xu1

    Linked Full Text
    Save to List
  5. 5
    Indole Cytosolic Phospholipase A2α Inhibitors: Discovery and in Vitro and in Vivo Characterization of 4-{3-[5-Chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic Acid, Efipladib.

    Indole Cytosolic Phospholipase A2α Inhibitors: Discovery and in Vitro and in Vivo Characterization of 4-{3-[5-Chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic Acid, Efipladib.

    John C. McKew, Katherine L. Lee, Marina W. H. Shen, Paresh Thakker, Megan A. Foley, Mark L. Behnke, Baihua Hu, Fuk-Wah Sum, Steve Tam, Yonghan Hu, Lihren Chen, Steven J. Kirincich, Ronald Michalak, Jennifer Thomason, Manus Ipek, Kun Wu, Lane Wooder, Manjunath K. Ramarao, Elizabeth A. Murphy, Debra G. Goodwin

    Linked Full Text
    Save to List

Search Tools: